← Leaderboards
Rachel Adria Katzenellenbogen
Seattle Children'S Hospital
$5,972,941
Attributed
$5,972,941
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $643.6K · FY2008–24$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,972,941 · 5
By mechanism
R01$4,066,670 · 1
U54$796,426 · 2
K08$671,895 · 1
R21$437,950 · 1
Top collaborators
No co-investigators on record.
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Donald L Sodora$27,419,798
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsHuman Papillomavirus 16Malignant NeoplasmsHuman Papilloma Virus InfectionCellsInfectionHigh RiskHuman PapillomavirusTumor ProgressionPathway InteractionsPoly(A)-Binding ProteinsWomanMalignant Neoplasm Of Cervix UteriViralHpv-High RiskDifferentiation And GrowthRegulationInvestigationCell GrowthOncogenicGenetic TranscriptionPreventiveCervicalOverexpression
Grant awards (27)
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$357,616
R01 · FY2024 · CA · contact PI
Project 3-- Determining biological and viral factors associated with clinical progression of cervical dysplasia in HIV-infected women$143,843
U54 · FY2024 · CA · contact PI
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$68,162
R01 · FY2024 · CA · contact PI
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$368,909
R01 · FY2023 · CA · contact PI
Project 3-- Determining biological and viral factors associated with clinical progression of cervical dysplasia in HIV-infected women$160,102
U54 · FY2023 · CA · contact PI
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$70,315
R01 · FY2023 · CA · contact PI
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$368,909
R01 · FY2022 · CA · contact PI
Project 3-- Determining biological and viral factors associated with clinical progression of cervical dysplasia in HIV-infected women$160,894
U54 · FY2022 · CA · contact PI
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$67,133
R01 · FY2022 · CA · contact PI
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$376,438
R01 · FY2021 · CA · contact PI
Project 3-- Determining biological and viral factors associated with clinical progression of cervical dysplasia in HIV-infected women$162,279
U54 · FY2021 · CA · contact PI
High-risk HPV E6: dysregulation of immortalization, growth, and differentiation through protein partnerships in HPV-associated cancers$376,438
R01 · FY2020 · CA · contact PI
Project 3-- Determining biological and viral factors associated with clinical progression of cervical dysplasia in HIV-infected women$169,308
U54 · FY2020 · CA · contact PI
Cellular RNA binding and regulation by NFX1-123 and its perturbation by high risk human papillomavirus E6$196,875
R21 · FY2019 · AI · contact PI
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancer$314,843
R01 · FY2018 · CA · contact PI
Cellular RNA binding and regulation by NFX1-123 and its perturbation by high risk human papillomavirus E6$212,625
R21 · FY2018 · AI · contact PI
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancer$87,707
R01 · FY2018 · CA · contact PI
Cellular RNA binding and regulation by NFX1-123 and its perturbation by high risk human papillomavirus E6$28,450
R21 · FY2018 · AI · contact PI
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancer$402,550
R01 · FY2017 · CA · contact PI
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancer$402,550
R01 · FY2016 · CA · contact PI
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancer$402,550
R01 · FY2015 · CA · contact PI
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancer$402,550
R01 · FY2014 · CA · contact PI
Regulation of Telomerase by NFX1$134,379
K08 · FY2012 · CA · contact PI
Regulation of Telomerase by NFX1$134,379
K08 · FY2011 · CA · contact PI
Regulation of Telomerase by NFX1$134,379
K08 · FY2010 · CA · contact PI
Regulation of Telomerase by NFX1$134,379
K08 · FY2009 · CA · contact PI
Regulation of Telomerase by NFX1$134,379
K08 · FY2008 · CA · contact PI